COMPARISON OF THE EFFECTS OF PARICALCITOL AND CALCITRIOL TREATMENTS ON OSTEOPROTEGERIN (OPG) LEVELS IN HEMODIALYSIS PATIENTS

ORUÇ A., YILDIZ A., Gul C. B., Aktas N., Bal O., Korkmaz S., ...Daha Fazla

ACTA MEDICA MEDITERRANEA, cilt.32, sa.2, ss.325-329, 2016 (SCI-Expanded) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 32 Sayı: 2
  • Basım Tarihi: 2016
  • Doi Numarası: 10.19193/0393-6384_2016_2_48
  • Dergi Adı: ACTA MEDICA MEDITERRANEA
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.325-329
  • Bursa Uludağ Üniversitesi Adresli: Evet

Özet

Introduction: Osteoprotegerin (OPG), a natural glycoprotein, which plays important roles on regulation and development of vascular calcification, is a key regulator molecule in bone turnover. Studies revealed different results about effects of vitamin D receptor activators (VDRAs) on OPG levels. This study investigated the changes in serum OPG levels and its relationships following VDRAs, paricalcitol and calcitriol treatments, in hemodialysis patients.